What is NDC 69315-701?

69315-701 is the product NDC for Ethacrynate Sodium, Ethacrynate sodium 50 mg/50mL injection, powder, lyophilized, for solution, listed with the FDA by Leading Pharma, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Leading Pharma, LLC, NDC labeler code 69315. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ethacrynate Sodium?

1 other product NDC are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ethacrynate Sodium NDC 69315-701 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)69315-701Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69315-0701Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69315-701-50	69315070150	1 VIAL, SINGLE-DOSE in 1 CARTON (69315-701-50) / 50 mL in 1 VIAL, SINGLE-DOSEMarketed from Jan 9, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ethacrynate Sodium
Generic name (nonproprietary): ethacrynate sodium
Active ingredients: Ethacrynate sodium — 50 mg/50mL
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: Leading Pharma, LLCNDC labeler code 69315
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208663
Marketing start: Jan 9, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Increased Diuresis at Loop of Henle (Physiologic effect)
Identifiers: Product ID 69315-701_f2c45a04-b3df-48cd-93e2-edb917a029cfSPL ID f2c45a04-b3df-48cd-93e2-edb917a029cfSPL set ID e24e7440-a958-6fd0-6bfe-1bd29e638657RxCUI 617325UNII K41MYV7MPMUPC 0369315701508
Pharmacologic class: Loop Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N469315070150 followed by a unit qualifier and the quantity

Package 69315-0701-50. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 14, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Ethacrynate sodium is indicated for treatment of edema when an agent with greater diuretic potential than those commonly employed is required. Treatment of the edema associated with congestive heart failure, cirrhosis of the liver and renal disease, including the nephrotic syndrome. Short-term management of ascites due to malignancy, idiopathic edema, and lymphedema. Short-term management of hospitalized pediatric patients, other than infants, with congenital heart disease or the nephrotic syndrome. Intravenous ethacrynate sodium is indicated when a rapid onset of diuresis is desired, e.g., in acute pulmonary edema, or when gastrointestinal absorption is impaired or ora…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 69315-701

What is NDC 69315-701?: 69315-701 is the product NDC for Ethacrynate Sodium, Ethacrynate sodium 50 mg/50mL injection, powder, lyophilized, for solution, listed with the FDA by Leading Pharma, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ethacrynate Sodium.
What is the active ingredient?: Ethacrynate sodium.
Who is the labeler?: Leading Pharma, LLC, NDC labeler code 69315. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ethacrynate Sodium?: 1 other product NDC are listed under this name. See all Ethacrynate Sodium NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ethacrynate Sodium NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Ethacrynate Sodium	Ethacrynate sodium 50 mg/50mL	Injection, Powder, For solutionIntravenous	Par Health USA, LLC	42023-157	42023-0157-01